Candriam S.C.A.

Q2 2022 13F-HR Holdings

Location
Strassen, Luxembourg, N4
Holdings as of
6/30/2022
Date filed
8/3/2022
Form type
13F-HR
Num holdings
782
Total value ($000)
$12,143,827
Net value change ($000)
-2,551,989 (-17.4%)
New positions
52
Sold out positions
86
Turnover %
3.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/13/2022 Next filing: 11/10/2022 SEC filing

Snapshot: Change Analysis

Compared to Q1 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MRK 26,987 9.3%
PG 26,672 15.1%
VZ 25,922 127.0%
PEP 23,750 87.6%
Turning Point Therapeutics, Inc. 23,402 173.2%
AZO 21,600 711.5%
GILD 21,554 20.7%
Biohaven Pharmaceutical Holding Co Ltd. 21,044 NEW
PFE 20,334 96.1%
ACET 18,740 NEW
Top Reduces (Value $000, Stocks/ETFs)
MSFT -199,237 -24.3%
GOOGL -129,251 -25.0%
AAPL -88,870 -16.9%
DIS -82,328 -46.6%
AMZN -79,883 -43.9%
NVDA -72,464 -42.5%
WM -68,129 -48.7%
C -63,975 -73.7%
SQM -59,221 -39.5%
ADBE -55,487 -35.3%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 288 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type